[Molecule targeted therapy for hematological malignancies].

  • Takashi Naoe
  • Published 2001 in Gan to kagaku ryoho. Cancer & chemotherapy


Over the past 20 years, there has been a marked increase in our knowledge of the molecular mechanisms of human hematological malignancies. The development of mechanism-based therapy is expected to extend the frontiers of chemotherapy. All-trans retinoic acid (ATRA) therapy for acute promyelocytic leukemia (APL), initially established as differentiation… (More)


Cite this paper

@article{Naoe2001MoleculeTT, title={[Molecule targeted therapy for hematological malignancies].}, author={Takashi Naoe}, journal={Gan to kagaku ryoho. Cancer & chemotherapy}, year={2001}, volume={28 2}, pages={131-4} }